community-based initiatives in ncd prevention and … · community-based initiatives in ncd...
TRANSCRIPT
Community-Based Initiatives in NCD
Prevention and Control
in North Carolina, USA
Eric D. Peterson, MD, MPH
Fred Cobb, MD Distinguished Professor of Medicine
Duke University School of Medicine
Director, Duke Clinical Research Institute (DCRI)
1990 2020
Lower Respiratory Infection 1 Ischemic heart disease
Diarrheal Disease 2 Depression
Perinatal 3 Road Traffic Accidents
Depression 4 Cerebrovascular
Ischemic Heart Disease 5 COPD
Cerebrovascular 6 Lower Respiratory Infection
Tuberculosis 7 Tuberculosis
Measles 8 War
Road Traffic Accidents 9 Diarrhoeal Disease
Congenital Diseases 10 HIV
Malaria 11 Perinatal Disease
COPD 12 Violence
Falls 13 Congenital
Iron-deficiency anemia 14 Self-inflicted injury
Protein calorie malnutrition 15 Bronchial and Lung Cancer
GLOBAL BURDEN OF CV DISEASE
Evolving View of CV Quality of Care:
Need for a Longitudinal Perspective
Getting Better Living w/ Illness/Disability (T1)
Coping w/ End of Life (T2)
Staying Healthy
Post Acute/
Rehabilitation
Phase
20 Prevention
Episode begins –
onset of symptoms
Post AMI Trajectory 2 (T2)
Adult with multiple co-morbidities
Focus on:
• Quality of Life
• Functional Status
• 20 Prevention Strategies
• Advanced Care Planning
• Advanced Directives
• Palliative Care/Symptom Control
Assessment of
Preferences
Acute
Phase
PHASE 1
PHASE 2 PHASE 3 PHASE 4
Episode ends –
1 year post AMI
20 Prevention (CAD with prior AMI)
Advanced Care Planning
Population at Risk
10 Prevention (no known CAD)
20 Prevention (CAD no prior AMI)
Post AMI Trajectory 1 (T1)
Relatively healthy adult
Focus on:
• Quality of Life
• Functional Status
• 20 Prevention Strategies
• Rehabilitation
• Advanced care planning
Targets for Implementation
Aware Applicable Able Acted On Agreed Adhered To Accepted
Providers: Evidence-based
Systems Improvement
Patients: engaged, adherent
Glasziou, et al. Evid. Based Nurs. 2005
Types of Implementation
Provider and patient education
Performance feedback
IT (monitors, reminders, decision-support)
Behavioral strategies (incentives)
New care models (team-based)
Community support/social networks
Policy change
Improving CV Care in NC
Across the Spectrum
Acute MI Care
CRUSADE/ACTION: Hospital feedback
RACE/Mission Lifeline: STEMI Systems
Smoothing Care Transitions
Patient Adherence: TRANSLATE ACS
Predictive/personalized interventions: GWTG
Primary Prevention
Ambulatory provider profiling
Engaging patients
Geospatial mapping and community
engagement
Participation in provider-led quality improvement (QI) efforts can improve CV care! NRMI, CRUSADE
AHA GWTG
ACC-NCDR
Means to Achieve better care Motivated local champions
Timely, valued feedback
Simple tools Standard orders, CPOE Pt-MD contract Chart documentation
Collaborative Teams
Provider Led Feedback
and QI Works
Concept
Outcomes
Clinical
Trials
Guidelines
Performance
Indicators
Measurement
Provider Led
Quality Improvement
Safe, Effective,
Long-term Use
Improvements in Guidelines Adherence And
Rates of Drug Overdosing Over Time
Mehta RH, et al AHJ 2007
27.5
24.9
22.1
0
5
10
15
20
25
30
35
Q4 2005 Q1 2006 Q2 2006R
ate
of
Exc
es
s D
osin
g
Co
mp
osit
e A
dh
ere
nce
Ra
tes
60%
70%
80%
90%
Q1
'02
Q1
'03
Q2
'04
Q3
'05
Q4
'06
Acute DischargeAlexander K, et al AHA 2007
Hospital Link Between Overall Guidelines
Adherence and Mortality
Peterson et al, JAMA 2006;295:1863-1912
5.95
5.16 4.97
4.16
5.064.63
4.15
6.31
0
1
2
3
4
5
6
7
<=25% 25 - 50% 50 - 75% >=75%
Hospital Composite Quality Quartiles
% I
n-H
osp
Mo
rtali
ty
Adjusted Unadjusted
Every 10% in guidelines adherence
10% in mortality (OR=0.90, 95% CI: 0.84-0.97)
The Need for Integrated Community Systems Door-to-Balloon w/ and w/o Transfer
Transfer in DTB Times Non-Transfer in DTB Times
96
114
145
53 61
68
Q3 10
98
117
141
55 62 69
Q4 10
93
114
145
57 64
Q1 11
97
119
149
57 64 71
Q2 11
Tim
e (
min
)
50
220
210
60
70
80
90
110
100
120
130
140
150
160
170
200
180
190
240
230
71
40
30
20
250
10
0
ACTION Registry-GWTG DATA: July 1, 2010 – June 30, 2011
Coordinated Systems of STEMI Care
Region
PCI hospital
Non PCI hospital strategy Transfer for PCI Lytics Mixed
New PCI hospitals New regions
Circulation Outcomes 2011
Direct to PCI Centers EMS 1st Medical Contact to Device Times
p<0.0001
• 60% used EMS
• EMS-transported patients had significantly shorter delays in both symptom onset-
to-arrival time (median, 89 versus 120 minutes; P<0.0001) and door-to-reperfusion
time (median door-to-balloon time, 63 versus 76 minutes; P<0.0001; median door-
to-needle time, 23 versus 29 minutes; P�0.0001).
• Subsequent study demonstrated that a plan of ‘bypassing’ hospitals without
capacity to do primary PCI reduced time to reperfusion and had trends towards
lower mortality
Circulation 2011
Mortality
The Need for Better Post Event Transitions
A ‘Voltage Drop’ in Secondary Prevention
Kramer, JM et al AHJ 2006
Trends in Post MI Discharge
Beta-blocker Use
1
Months
3 6 12 15 Index MI
Hospitalization
STEMI/NSTEMI
PCI
DCRI FOLLOW-UP - rehospitalizations
- medication use
- collect bills and records
validate events
q assess care costs
SITE - consent patient for follow-up
- enter data from index hospitalization
After the patient goes home…
In-hospital
Persistence of Evidence-based
Therapies Post Discharge
60
70
80
90
100
Aspirin ADP inhibitor Statin B-blocker ACE/ARB
Discharge 6 wk 6 mo 12 mo
Evolution of Duke Medicine
Duke University Health System
Duke University Health Research
School Clinics
Federally Qualified Health Center
Local Primary Care Practices and Practice Networks
Local Medicaid Network
Durham Public Health System
DUKE Community Engagement Model
Social Integrators Universities DTMI Community Engagement
Data architecture and analytics (who, what, where)
COMMUNITY PARTNERSHIP ZONE CLINICAL CARE
Accountability: real-time monitoring and evaluation (weight, HbA1C, blindness, amputation, foot ulcers, nephropathy, retinopathy, stroke, MI,
sudden death, heart failure)
Decision support systems
Insurers Employers
Informed, activated population Strong community organizations
Healthy public policy Supportive env’ts/families
Public sector Media and other institutions
Proactive practice team Informed, activated
patients
Community based clinical care Activated patients Lifestyle programs
Regular glucose monitoring
Medication adherence Knowledge generation & transfer
Ongoing mobilization, capacity-bldg Advocacy
Fee
db
ack
loo
p
Fee
db
ack
loo
p
Readmission: An Opportunity!
15
.34
14
.51
17
.26
11.9
8
15
.63
15
.96
15
.00
10
.34
18
.10
13
.61
12
.70
13
.75
14
.20
15
.14
13
.32
13
.37
12
.54
11
.07
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
16.00
18.00
20.00
2008-4 2009-1 2009-2 2009-3 2009-4 2010-1 2010-2 2010-3 2010-4
AMI All Cause 30-Day Readmission Rates
AMI - DUKE
AMI - US N&W Heart
How to Reduce Readmissions
Characterize variation in readmissions following ACS
and Heart Failure
Identify modifiable MD, hospital and system factors
associated with readmission
Duke Interventions
Phone calls at 72 hours after discharge for all cardiac patients
Address medications compliance, verify follow-up schedule, identify and address
complications or concerns
On-call cardiologist schedule
Attending on-call 24/7 for any patient or referring provider calls
7-day appointment scheduling with Primary Care or Cardiology
New scheduling process to improve appointment scheduling prior to discharge
Electronic discharge paperwork
Cardiology use near 70% and CT Surgery in process
Pharmacists support medication-related education and follow-up
AMI: Medicare patients with a) h/o non-adherence to CV meds; or b) perceived
poor understanding of medication regimen
Predictive Modeling*
at the point of care
i
What is the patient’s risk of readmission
within 30 days?
What is the patient’s risk of death?
* Compliments of Zubin Eapen
“The future of hypertension control may be getting
more encouraging. This optimism doesn’t stem from
the discovery of a new drug, but rather from the dawning
of the information age in ambulatory medicine.”
Peterson ED Arch Int Med 2008;168:259-60
Preventing Disease:
The Next Frontier
All Rights Reserved, Duke Medicine 2008
02
46
810
Num
ber
of
Pro
viders
0 10 20 30 40 50% of Patients with Uncontrolled Hypertension
Distribution of Rates of Uncontrolled HypertensionBy Provider
Overall: 27.2% Patients
not controlled
All Rights Reserved, Duke Medicine 2008
Distribution of Provider-Specific Rates of Uncontrolled Hypertension
0
10
20
30
40
50
60
70
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46
Provider Rank
Pe
rce
nt
Un
co
ntr
olle
d
After adjusting for predictors:
Provider variability significant (p<0.001)
Threefold variability across providers
All Rights Reserved, Duke Medicine 2008
42%
3%
7%
5%
43%
Medication Change
No ChangesRecommended
Follow Up with OtherProvider
Recommend HomeMonitoring
Diet and Exercise Changes
Response to Uncontrolled Blood Pressure
57%
Target
for QI
All Rights Reserved, Duke Medicine 2008
Future Directions – Improving HTN Control
• Provider feedback
– Starting July 15, 2011
– Providers receive quarterly clinician-specific feedback reports via Duke Heart Center
– Measure Pre- Post-intervention BP Control vs concurrent control group
– Move to multi-specialty, multi system intervention (primary care and UNC)
• Patient feedback
– Identify a cohort of patients with uncontrolled BP
– Randomize to feedback vs. no feedback
– Assess: patient provider satisfaction, responses, BP control rates
NEJM Oct 28 2010;383:18:
The Office Should Not Be the End of Care!
Home-Based Health Care
Model for Home-based Health
Consumer Electronics
Gateway
World Wide Web
Web Interfaces for
EMR / PHR / HIE
Health Monitoring
Devices
Family
Interactivity
and Alerts
Provider Portal,
Alerts and Tools
Interactive
Communication
33
Blood Pressure Monitoring Application
• Store, analyze, and/or share Blood
Pressure data
• Medication hx, refill information
• Accessible by patient, MD or case
manager
“Patient Portal” “Provider Portal”
• Data inputs
• Reports
• Risk Tools
• Trackers
• AHA Content
• Patient Monitoring
• Enhanced
Communication
• Notification
• Reporting
Heart360 Cardiovascular Wellness Center
35
SPRITE Evaluation: Randomized Trial
Enrolled
Randomization
Control
ARM 1 ARM 2 ARM 3
H360 H360 +
Disease Manager
Excluded
• Same as BPMC +
• DM: Nurse/MD who
monitors and responds to
BPMC data
• Keeps primary MD
informed of care changes
• Home BP monitoring
• Link BP data, meds, to
patient and provider
Primary Outcome: BP Control
Secondary Outcomes: Med Adherence, Other CRF Control, Patient Satisfaction
• Usual standard of care
• Printed Education tools
• Assessment of endpoints
(BP, med use, etc)
at routine intervals
Multiple Clinics
CICI Team: Nancy Allen LaPointe, Midge Bowers, Khadijah Breathett, Cedric
Bright, Robert Califf, Katrina Damon, Sharon Elliott-Bynum, Olivia Fu, Bradi
Granger, Karol Harshaw-Ellis, Elaine Hart-Brothers, Carolyn Lekavich, Robin
Mathews, Vincent Miller, John Middleton, Sahar Naderi, Eric D. Peterson, Beth
Phillips, Maria Small, Bimal R. Shah, Kevin L. Thomas, Kristin D. Thomas, Elyse
Thompson, Patrick Wayte
Check It, Change It: The Durham Blood Pressure Challenge
A public-private partnership
to improve our community’s
health
37
Target
Population
Community
Connected
Care
Enrollment & Individual
Assessment w/ provider
Remote
Monitoring
Community
Ambassador
APC
Outcomes:
• ↓ BP
• ↓ admissions for CVD
• Process & Impact metrics
Measurement &
Evaluation*:
•Heart360®
•Chart audits
•DSR
Provider
Engagement
Durham County residents with HTN
Pharmacies
Program Overview: Vascular Intervention Project)
DOC CAARE & Samaritan Lincoln Private
Patient Engagement
Patient empowered to begin
disease management behaviors-
tracking health factors,
medications, lifestyle changes;
receiving patient education;
and partnering with their
provider.
Collaborative Community Care
American Heart Association 38 Confidential
Patient OnBoarding
Clinic
Pharmacy
Employer
Community
Center
Community
Clinic
Provider
Provider
and/or
Kiosks
Patient Coach
Website
Kiosks
Health Assessment
Kiosks
Campaign Website
Kiosks
and/or
Pharmacist
Provider Engagement
Provider Connection enabled
regardless of recruitment channel.
•Motivational/Engagement Effort
• Improved Standard of Care
Intervention Channel
“Humanity’s greatest advances are not in its discoveries – but in how those discoveries are applied ...”
Bill Gates, June 7, 2007
Harvard Commencement Address